Today's biotech news includes Medicaid coverage in North Carolina, a $42,250 Gilead drug, and Merck's experimental RSV antibody.

Posted 2024-01-22T19:47:52Z - Updated 2024-01-22T20:50:07Z By David Arkin This article was written for our sponsor, North Carolina Biotechnology Center ...

DURHAM, N.C. — Pharmaceutical maker Merck & Co. is investigating how a noose ended up on the campus of its plant in Durham, North Carolina, according to a published report. Merck operates a 262 ...

DURHAM, N.C. (AP) — The global pharmaceutical manufacturer Merck is set to expand in North Carolina, creating about 425 new jobs. News outlets report the company is expected to build a 225,000 ...

American pharmaceutical company Merck is investigating after a noose was found at its plan in Durham, North Carolina, The News and Observer reports.The newspaper reports that a contractor foun… ...

A&T). The Merck Biotechnology Learning Center, a 4,025-square-foot facility, offers advanced training and discovery opportunities for N.C. A&T students pursuing careers in biotechnology.

Pharmaceutical maker Merck & Co. is investigating how a noose ended up on the campus of its plant in Durham, North Carolina, according to a published report. “Actions such as these will NOT be ...

Merck testing drone delivery for vaccines in North Carolina By Heather Landi Oct 20, 2020 4:05pm Innovation Patient-Centered Care Pharmaceuticals Supply Chain ...

North Carolina Commerce Secretary Anthony M. Copeland paid a visit to the site on December 4 to announce that Merck will spend $57 million to establish a filling and packaging line for its RotaTeq ...

Merck plans to spend $300 million to expand its vaccine plant in Durham, N.C., according to the Triangle Business Journal. Innovative vaccines such as Gardasil, which can help prevent cervical ...